ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LRCX Lam Research Corporation

899.74
44.88 (5.25%)
After Hours
Last Updated: 23:06:50
Delayed by 15 minutes
Share Name Share Symbol Market Type
Lam Research Corporation NASDAQ:LRCX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  44.88 5.25% 899.74 897.36 899.89 924.74 881.59 893.50 1,938,392 23:06:50

Lam Research Corporation Reports Financial Results for the Quarter Ended June 30, 2024

31/07/2024 9:05pm

PR Newswire (US)


Lam Research (NASDAQ:LRCX)
Intraday Stock Chart


Wednesday 31 July 2024

Click Here for more Lam Research Charts.

FREMONT, Calif., July 31, 2024 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 30, 2024 (the "June 2024 quarter").

Highlights for the June 2024 quarter were as follows:

  • Revenue of $3.87 billion.
  • U.S. GAAP gross margin of 47.5%, U.S. GAAP operating income as a percentage of revenue of 29.1%, and U.S. GAAP diluted EPS of $7.78.
  • Non-GAAP gross margin of 48.5%, non-GAAP operating income as a percentage of revenue of 30.7%, and non-GAAP diluted EPS of $8.14.

 

Key Financial Data for the Quarters Ended

June 30, 2024 and March 31, 2024

(in thousands, except per-share data, percentages, and basis points)

 


U.S. GAAP



June 2024


March 2024


Change Q/Q

Revenue


$                3,871,507


$                3,793,558


+2.1 %

Gross margin as percentage of revenue


47.5 %


47.5 %


+ 0 bps

Operating income as percentage of revenue


29.1 %


27.9 %


+ 120 bps

Diluted EPS


$                          7.78


$                          7.34


+6.0 %








Non-GAAP



June 2024


March 2024


Change Q/Q

Revenue


$                3,871,507


$                3,793,558


+2.1 %

Gross margin as percentage of revenue


48.5 %


48.7 %


- 20 bps

Operating income as percentage of revenue


30.7 %


30.3 %


+ 40 bps

Diluted EPS


$                          8.14


$                          7.79


+4.5 %

U.S. GAAP Financial Results

For the June 2024 quarter, revenue was $3,872 million, gross margin was $1,840 million, or 47.5% of revenue, operating expenses were $714 million, operating income was 29.1% of revenue, and net income was $1,020 million, or $7.78 per diluted share on a U.S. GAAP basis. This compares to revenue of $3,794 million, gross margin of $1,801 million, or 47.5% of revenue, operating expenses of $743 million, operating income of 27.9% of revenue, and net income of $966 million, or $7.34 per diluted share, for the quarter ended March 31, 2024 (the "March 2024 quarter"). The June 2024 quarter included 13 weeks; the March 2024 quarter included 14 weeks.

Non-GAAP Financial Results

For the June 2024 quarter, non-GAAP gross margin was $1,876 million, or 48.5% of revenue, non-GAAP operating expenses were $689 million, non-GAAP operating income was 30.7% of revenue, and non-GAAP net income was $1,067 million, or $8.14 per diluted share. This compares to non-GAAP gross margin of $1,848 million, or 48.7% of revenue, non-GAAP operating expenses of $698 million, non-GAAP operating income of 30.3% of revenue, and non-GAAP net income of $1,024 million, or $7.79 per diluted share, for the March 2024 quarter.

"Lam's June quarter results came in above the midpoint of our guidance, driven by continued solid execution and growth in our customer support business group," said Tim Archer, Lam Research's President and Chief Executive Officer. "We are making strategic investments in R&D and our operations to position Lam to outperform in what we believe will be a multi-year period of strong wafer fab equipment spending."

Balance Sheet and Cash Flow Results

Cash and cash equivalents and restricted cash balances increased to $5.9 billion at the end of the June 2024 quarter compared to $5.7 billion at the end of the March 2024 quarter. Cash generated from operating activities totaling $862.4 million was offset by $373.6 million of share repurchases, including net share settlement of employee stock-based compensation; $261.5 million of dividends paid to stockholders; and $100.7 million of capital expenditures.

Deferred revenue at the end of the June 2024 quarter decreased to $1,552 million compared to $1,746 million as of the end of the March 2024 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $98 million as of June 30, 2024 and $107 million as of March 31, 2024.

Revenue

The geographic distribution of revenue during the June 2024 quarter is shown in the following table:

Region

Revenue

China

39 %

Korea

18 %

Taiwan

15 %

United States

10 %

Southeast Asia

8 %

Japan

7 %

Europe

3 %

The following table presents revenue disaggregated between system and customer support-related revenue:


Three Months Ended


June 30,
2024


March 31,
2024


June 25,
2023


(In thousands)

Systems revenue

$      2,169,885


$      2,395,817


$      1,710,359

Customer support-related revenue and other

1,701,622


1,397,741


1,496,898


$      3,871,507


$      3,793,558


$      3,207,257







Systems revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended September 29, 2024, Lam is providing the following guidance:


U.S. GAAP


Reconciling
Items


Non-GAAP












Revenue

$4.05 Billion

+/-

$300 Million



$4.05 Billion

+/-

$300 Million

Gross margin as a percentage of revenue

46.9 %

+/-

1 %


$   3.1

Million


47.0 %

+/-

1 %

Operating income as a percentage of revenue

29.4 %

+/-

1 %


$   3.8

Million


29.5 %

+/-

1 %

Net income per diluted share

$7.97

+/-

$0.75


$   4.3

Million


$8.00

+/-

$0.75

Diluted share count

131 million



131 million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3.1 million.
  • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3.8 million.
  • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3.8 million; amortization of debt discounts, $0.8 million; and associated tax benefit for non-GAAP items ($0.3 million); totaling $4.3 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2024 and March 2024 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, net restructuring charges, transformational costs, and the net income tax effect of non-GAAP items. The March 2024 non-GAAP results also exclude expenses associated with the impairment of long-lived assets.

Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at https://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our investment in R&D and our operations; our competitive positioning and potential to outperform within our industry; and our expectations for the strength of future wafer fabrication equipment spending. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 25, 2023, and our quarterly report on Form 10–Q for the fiscal quarter ended March 31, 2024. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)

Consolidated Financial Tables Follow.

 

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)



Three Months Ended


Twelve Months Ended


June 30,
2024


March 31,
2024


June 25,
2023


June 30,
2024


June 25,
2023


(unaudited)


(unaudited)


(unaudited)


(unaudited)


(1)

Revenue

$  3,871,507


$  3,793,558


$  3,207,257


$ 14,905,386


$ 17,428,516

Cost of goods sold

2,026,133


1,977,820


1,737,682


7,809,220


9,573,425

Restructuring charges, net - cost of goods sold

5,276


15,202


11,446


43,375


78,166

Total cost of goods sold

2,031,409


1,993,022


1,749,128


7,852,595


9,651,591

Gross margin

1,840,098


1,800,536


1,458,129


7,052,791


7,776,925

Gross margin as a percent of revenue

47.5 %


47.5 %


45.5 %


47.3 %


44.6 %

Research and development

497,829


512,274


401,951


1,902,444


1,727,162

Selling, general and administrative

216,477


215,904


199,831


868,247


832,753

Restructuring charges, net - operating expenses

(768)


15,246


1,742


18,187


42,150

Total operating expenses

713,538


743,424


603,524


2,788,878


2,602,065

Operating income

1,126,560


1,057,112


854,605


4,263,913


5,174,860

Operating income as a percent of revenue

29.1 %


27.9 %


26.6 %


28.6 %


29.7 %

Other income (expense), net

27,796


36,073


9,010


96,309


(65,650)

Income before income taxes

1,154,356


1,093,185


863,615


4,360,222


5,109,210

Income tax expense

(134,074)


(127,359)


(61,078)


(532,450)


(598,279)

Net income

$  1,020,282


$     965,826


$     802,537


$   3,827,772


$   4,510,931

Net income per share:










Basic

$            7.81


$            7.38


$            5.99


$          29.13


$          33.30

Diluted

$            7.78


$            7.34


$            5.97


$          29.00


$          33.21

Number of shares used in per share calculations:










Basic

130,633


130,838


134,052


131,410


135,472

Diluted

131,112


131,518


134,392


131,995


135,834

Cash dividend declared per common share

$            2.00


$            2.00


$          1.725


$             8.00


$             6.90













(1)

Derived from audited financial statements

 

 LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)



June 30,
2024


March 31,
2024


June 25,
2023


(unaudited)


(unaudited)


(1)

ASSETS






Cash and cash equivalents

$              5,847,856


$              5,672,232


$              5,337,056

Accounts receivable, net

2,519,250


2,203,707


2,823,376

Inventories

4,217,924


4,322,967


4,816,190

Prepaid expenses and other current assets

298,190


289,530


251,790

Total current assets

12,883,220


12,488,436


13,228,412

Property and equipment, net

2,154,518


2,181,741


1,856,672

Goodwill and intangible assets

1,765,073


1,768,998


1,790,943

Other assets

1,941,917


1,840,475


1,905,616

Total assets

$            18,744,728


$            18,279,650


$            18,781,643

LIABILITIES AND STOCKHOLDERS' EQUITY






Current portion of long-term debt and finance lease obligations

$                  504,814


$                  505,066


$                      8,358

Other current liabilities

3,833,624


3,925,023


4,176,560

Total current liabilities

4,338,438


4,430,089


4,184,918

Long-term debt and finance lease obligations

4,478,520


4,478,385


5,003,183

Income taxes payable

813,304


832,397


882,084

Other long-term liabilities

575,012


516,678


501,286

Total liabilities

10,205,274


10,257,549


10,571,471

Stockholders' equity (2)

8,539,454


8,022,101


8,210,172

Total liabilities and stockholders' equity

$            18,744,728


$            18,279,650


$            18,781,643









(1)

Derived from audited financial statements

(2)

Common shares issued and outstanding were 130,377 as of June 30, 2024, 130,736 as of March 31, 2024, and 133,297 as of June 25, 2023

 

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)



Three Months Ended


Twelve Months Ended


June 30,
2024


March 31,
2024


June 25,
2023


June 30,
2024


June 25,
2023


(unaudited)


(unaudited)


(unaudited)


(unaudited)


(1)

CASH FLOWS FROM OPERATING ACTIVITIES:










Net income

$        1,020,282


$           965,826


$           802,537


$        3,827,772


$        4,510,931

Adjustments to reconcile net income to net cash provided by operating activities:










Depreciation and amortization

88,357


89,922


89,604


359,699


342,432

Deferred income taxes

(61,375)


(24,621)


(38,960)


(198,981)


(172,061)

Equity-based compensation expense

79,092


76,854


68,495


293,058


286,600

Other, net

(3,999)


10,210


40,761


10,243


52,298

Changes in operating assets and liabilities

(259,927)


266,645


160,288


360,478


158,738

Net cash provided by operating activities

862,430


1,384,836


1,122,725


4,652,269


5,178,938

CASH FLOWS FROM INVESTING ACTIVITIES:










Capital expenditures and intangible assets

(100,748)


(103,654)


(78,670)


(396,670)


(501,568)

Business acquisitions, net of cash acquired





(119,955)

Net maturities and sale of available-for-sale securities


14,650


26,280


37,766


98,132

Other, net

(865)


(3,356)


(2,790)


(11,710)


(11,171)

Net cash used for investing activities

(101,613)


(92,360)


(55,180)


(370,614)


(534,562)

CASH FLOWS FROM FINANCING ACTIVITIES:










Principal payments on debt, including finance lease obligations

(949)


(1,060)


(2,061)


(256,104)


(23,206)

Treasury stock purchases

(373,550)


(980,561)


(869,014)


(2,842,807)


(2,017,012)

Dividends paid

(261,462)


(262,707)


(232,336)


(1,018,915)


(907,907)

Reissuance of treasury stock related to employee stock purchase plan

66,885



64,903


119,966


109,899

Proceeds from issuance of common stock

2,796


8,235


3,438


15,553


11,111

Other, net

(7,871)


300


(2,916)


(13,543)


(3,552)

Net cash used for financing activities

(574,151)


(1,235,793)


(1,037,986)


(3,995,850)


(2,830,667)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(9,616)


(8,452)


1,477


(22,374)


128

Net change in cash, cash equivalents, and restricted cash

177,050


48,231


31,036


263,431


1,813,837

Cash, cash equivalents, and restricted cash at beginning of period (2)

5,673,753


5,625,522


5,556,336


5,587,372


3,773,535

Cash, cash equivalents, and restricted cash at end of period (2)

$        5,850,803


$        5,673,753


$        5,587,372


$        5,850,803


$        5,587,372













(1)

Derived from audited financial statements

(2)

Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets

 

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)



Three Months Ended


June 30,
2024


March 31,
2024

Revenue

$       3,871,507


$       3,793,558

Gross margin

$       1,876,345


$       1,847,752

Gross margin as percentage of revenue

48.5 %


48.7 %

Operating expenses

$          689,133


$          697,672

Operating income

$       1,187,212


$       1,150,080

Operating income as a percentage of revenue

30.7 %


30.3 %

Net income

$       1,066,890


$       1,024,206

Net income per diluted share

$                8.14


$                7.79

Shares used in per share calculation - diluted

131,112


131,518

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited)



Three Months Ended


June 30,
2024


March 31,
2024

U.S. GAAP net income

$          1,020,282


$             965,826

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations - cost of goods sold

3,076


3,076

Elective deferred compensation ("EDC")  related liability valuation increase - cost of goods sold

2,488


6,963

Restructuring charges, net - cost of goods sold

5,276


15,202

Transformational costs - cost of goods sold

25,407


13,270

Impairment of long-lived assets - cost of goods sold


8,705

EDC related liability valuation increase - research and development

4,479


12,534

Transformational costs - research and development

8,469


4,423

Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative

770


770

EDC related liability valuation increase - selling, general and administrative

2,986


8,356

Transformational costs - selling, general and administrative

8,469


4,423

Restructuring charges, net - operating expenses

(768)


15,246

Amortization of note discounts - other income (expense), net

759


753

Gain on EDC related asset - other income (expense), net

(9,643)


(26,495)

Net income tax benefit on non-GAAP items

(5,160)


(8,846)

Non-GAAP net income

$          1,066,890


$          1,024,206

Non-GAAP net income per diluted share

$                   8.14


$                   7.79

U.S. GAAP net income per diluted share

$                   7.78


$                   7.34

U.S. GAAP and non-GAAP  number of shares used for per diluted share calculation

131,112


131,518

 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,

 Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited) 



Three Months Ended


June 30,
2024


March 31,
2024

U.S. GAAP gross margin

$       1,840,098


$       1,800,536

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations

3,076


3,076

EDC related liability valuation increase

2,488


6,963

Restructuring charges, net

5,276


15,202

Transformational costs

25,407


13,270

Impairment of long-lived assets


8,705

Non-GAAP gross margin

$       1,876,345


$       1,847,752

U.S. GAAP gross margin as a percentage of revenue

47.5 %


47.5 %

Non-GAAP gross margin as a percentage of revenue

48.5 %


48.7 %

U.S. GAAP operating expenses

$          713,538


$          743,424

Pre-tax non-GAAP items:




Amortization related to intangible assets acquired through certain business combinations

(770)


(770)

EDC related liability valuation increase

(7,465)


(20,890)

Restructuring charges, net

768


(15,246)

Transformational costs

(16,938)


(8,846)

Non-GAAP operating expenses

$          689,133


$          697,672

U.S. GAAP operating income

$       1,126,560


$       1,057,112

Non-GAAP operating income

$       1,187,212


$       1,150,080

U.S. GAAP operating income as percent of revenue

29.1 %


27.9 %

Non-GAAP operating income as a percent of revenue

30.7 %


30.3 %

Lam Research Corporation Contact:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

(PRNewsfoto/Lam Research)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-june-30-2024-302211449.html

SOURCE Lam Research Corporation

Copyright 2024 PR Newswire

1 Year Lam Research Chart

1 Year Lam Research Chart

1 Month Lam Research Chart

1 Month Lam Research Chart

Your Recent History

Delayed Upgrade Clock